The art of the alliance

Securing a partner is only the beginning—you then have to put substantial effort and resources into keeping the collaboration functioning and productive.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    Czerepak, E.A. & Ryser, S. Nat. Rev. Drug Discov. 7, 197–198 (2008).

  2. 2

    Danzon, P.M., Nicholson, S. & Pereira, N.S. J. Health Econ. 24, 317–339 (2005).

  3. 3

    DiMasi, J.A. & Grabowski, H.G. Managerial and Decision Economics 28, 469–479 (2007).

  4. 4

    Pammolli, F., Magazzini, L. & Riccaboni, M. Nat. Rev. Drug Discov. 10, 428–438 (2011).

  5. 5

    Pharmaceutical Research and Manufacturers of America. Pharmaceutical Industry Profile 2011 (PhRMA, Washington, DC, April 2011).

  6. 6

    Berndt, E.R. & Aitken, M.L. Brand Loyalty, Generic Entry and Price Competition in Pharmaceuticals in the Quarter Century After the 1984 Waxman-Hatch Legislation, Working Paper 16431 (The National Bureau of Economic Research, October 2010).

  7. 7

    Munos, B. Nat. Rev. Drug Discov. 8, 959–968 (2009).

  8. 8

    Ledford, H. Nature 474, 433–434 (2011).

  9. 9

    Garnier, J.-P. Harvard Business Review 86, 68–76 (2008).

  10. 10

    Kale, P. & Singh, H. Academy of Management Perspectives 45–62 (August 2009).

  11. 11

    Munos, B.H. & Chin, W.W. Sci. Transl. Med. 3, 89cm16 (2011).

Download references

Author information

Correspondence to Garry E Menzel or Kleanthis G Xanthopoulos.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Menzel, G., Xanthopoulos, K. The art of the alliance. Nat Biotechnol 30, 313–315 (2012). https://doi.org/10.1038/nbt.2150

Download citation

Further reading